Sequel Pharmaceuticals, Inc


Sequel Pharma LLC. is a privately held, specialty pharmaceutical company that acquires, develops, and markets products in select therapeutic areas, with a mission to improve the lives of patients by commercializing specialty pharmaceutical products.

Industries

biotechnology
health-care
medical

Nr. of Employees

small (1-50)

Sequel Pharmaceuticals, Inc

San Diego, California, United States, North America


Products

Metoprolol succinate extended-release — U.S. marketing rights (divested)

Reference to a U.S. marketing rights transfer for an extended-release metoprolol succinate product; the company directed medical and safety inquiries to the acquiring commercial partner.


Services

Acquisition and licensing of pharmaceutical products

Transaction services to acquire or license marketing rights and product assets for inclusion in a specialty pharmaceutical portfolio.

Product development for specialty pharmaceuticals

Development management for specialty pharmaceutical assets, including formulation and progression through development milestones.

Commercialization and marketing services

Commercial launch and marketing activities for specialty pharmaceutical products in selected therapeutic areas.

Expertise Areas

  • Specialty pharmaceutical commercialization
  • Product acquisition and licensing
  • Pharmaceutical product development
  • Regulatory compliance and submissions
  • Show More (3)

Key Technologies

  • Pharmaceutical formulation and product development
  • Drug delivery technologies
  • Regulatory submission processes (NDA/marketing applications)
  • Product lifecycle and portfolio management
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.